On November 13, 2023, Viridian Therapeutics, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.7 USD | +0.77% | -4.46% | -37.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.49% | 868M | |
+1.45% | 42.86B | |
+11.65% | 42.74B | |
+45.04% | 41.36B | |
-8.83% | 27.68B | |
+7.70% | 25.15B | |
-23.10% | 18.63B | |
+30.43% | 12.37B | |
-2.19% | 11.92B | |
+7.38% | 11.21B |
- Stock Market
- Equities
- VRDN Stock
- News Viridian Therapeutics, Inc.
- Viridian Therapeutics, Inc. announced that it has received $185.000072 million in funding from a group of investors